{"id":12518,"date":"2003-12-01T06:19:48","date_gmt":"2003-12-01T06:19:48","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=12518"},"modified":"2016-11-04T15:55:33","modified_gmt":"2016-11-04T15:55:33","slug":"9th-european-aids-conference-eacs","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/12518","title":{"rendered":"9th European AIDS Conference (EACS), 25-29 October 2003, Warsaw"},"content":{"rendered":"<p><strong>The European AIDS Conference, organised by the European AIDS Clinical Society (EACS) every two years, was formally linked this year with a new resistance and pharmacology workshop. Prior to the meeting the organisers also provided an intensive training programme for clinicians.<\/strong><\/p>\n<p>Reports in this issue of HTB include:<\/p>\n<ul>\n<li><a title=\"Permanent link to Lower doses of d4T produce similar efficacy and reduced side effects\" href=\"https:\/\/i-base.info\/htb\/2789\" rel=\"bookmark\">Lower doses of d4T produce similar efficacy and reduced side effects<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Switching from efavirenz to nevirapine to avoid CNS side effects\" href=\"https:\/\/i-base.info\/htb\/12502\" rel=\"bookmark\">Switching from efavirenz to nevirapine to avoid CNS side effects<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Interruption of treatment is safe for those who started too early\" href=\"https:\/\/i-base.info\/htb\/12498\" rel=\"bookmark\">Interruption of treatment is safe for those who started too early<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to T20 is cost effective for UK purchasers\" href=\"https:\/\/i-base.info\/htb\/12481\" rel=\"bookmark\">T20 is cost effective for UK purchasers<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Intrauterine exposure to efavirenz\" href=\"https:\/\/i-base.info\/htb\/12472\" rel=\"bookmark\">Intrauterine exposure to efavirenz<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to African patients and adherence in the UK\" href=\"https:\/\/i-base.info\/htb\/12464\" rel=\"bookmark\">African patients and adherence in the UK<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Five-year results of Kaletra-based therapy in treatment-na\u00efve HIV patients\" href=\"https:\/\/i-base.info\/htb\/12459\" rel=\"bookmark\">Five-year results of Kaletra-based therapy in treatment-na\u00efve HIV patients<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to IL-2 effectively increases CD4 count in people with low CD4 nadir\" href=\"https:\/\/i-base.info\/htb\/12448\" rel=\"bookmark\">IL-2 effectively increases CD4 count in people with low CD4 nadir<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Hepatitis coinfection: incidence in Europe and response to transplant\" href=\"https:\/\/i-base.info\/htb\/12443\" rel=\"bookmark\">Hepatitis coinfection: incidence in Europe and response to transplant<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Rituximab plus CDE for HIV-related Non-Hodgkins Lymphoma (NHL)\" href=\"https:\/\/i-base.info\/htb\/12435\" rel=\"bookmark\">Rituximab plus CDE for HIV-related Non-Hodgkins Lymphoma (NHL)<\/a><\/li>\n<\/ul>\n<p><em>[Note: abstracts have since been posted to the EACS abstract archive:\u00a0<a href=\"http:\/\/www.abstractserver.com\/eacsabstractarchive\">http:\/\/www.abstractserver.com\/eacsabstractarchive<\/a>]<\/em><\/p>\n\n<p>Other reports from this meeting are included on the following sites.<\/p>\n<p>HIVandHepatitis.com<br \/>\n<a href=\"http:\/\/www.hivandhepatitis.com\"> http:\/\/www.hivandhepatitis.com<\/a><\/p>\n<p>The Body.com<br \/>\n<a href=\"http:\/\/www.thebody.com\"> http:\/\/www.thebody.com<\/a><\/p>\n<p>NATAP<br \/>\n<a href=\"http:\/\/www.natap.org\"> http:\/\/www.natap.org<\/a><\/p>\n<p>Medscape (requires one-time free registration)<br \/>\n<a href=\"http:\/\/www.mescape.com\"> http:\/\/www.mescape.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The European AIDS Conference, organised by the European AIDS Clinical Society (EACS) every two years, was formally linked this year with a new resistance and pharmacology workshop. Prior to the meeting the organisers also provided an intensive training programme for &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[12,75],"class_list":["post-12518","post","type-post","status-publish","format-standard","hentry","category-conference-reports","tag-conference-index","tag-eacs-9th-2003"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/12518","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=12518"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/12518\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=12518"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=12518"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=12518"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}